These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. A role for fosfomycin treatment in children for prevention of haemolytic-uraemic syndrome accompanying Shiga toxin-producing Escherichia coli infection. Tajiri H; Nishi J; Ushijima K; Shimizu T; Ishige T; Shimizu M; Tanaka H; Brooks S Int J Antimicrob Agents; 2015 Nov; 46(5):586-9. PubMed ID: 26391378 [TBL] [Abstract][Full Text] [Related]
6. Interventions for Shiga toxin-producing Escherichia coli gastroenteritis and risk of hemolytic uremic syndrome: A population-based matched case control study. Myojin S; Pak K; Sako M; Kobayashi T; Takahashi T; Sunagawa T; Tsuboi N; Ishikura K; Kubota M; Kubota M; Igarashi T; Morioka I; Miyairi I PLoS One; 2022; 17(2):e0263349. PubMed ID: 35120154 [TBL] [Abstract][Full Text] [Related]
7. Is Shigatoxin 1 protective for the development of Shigatoxin 2-related hemolytic uremic syndrome in children? Data from the ItalKid-HUS Network. Ardissino G; Possenti I; Vignati C; Daprai L; Capone V; Brigotti M; Luini MV; Consonni D; Montini G Pediatr Nephrol; 2020 Oct; 35(10):1997-2001. PubMed ID: 32734345 [TBL] [Abstract][Full Text] [Related]
8. Unusual severe case of hemolytic uremic syndrome due to Shiga toxin 2d-producing E. coli O80:H2. Wijnsma KL; Schijvens AM; Rossen JWA; Kooistra-Smid AMDM; Schreuder MF; van de Kar NCAJ Pediatr Nephrol; 2017 Jul; 32(7):1263-1268. PubMed ID: 28343354 [TBL] [Abstract][Full Text] [Related]
10. Case-management protocol for bloody diarrhea as a model to reduce the clinical impact of Shiga toxin-producing Escherichia coli infections. Experience from Southern Italy. Loconsole D; Giordano M; Laforgia N; Torres D; Santangelo L; Carbone V; Parisi A; Quarto M; Scavia G; Chironna M; Eur J Clin Microbiol Infect Dis; 2020 Mar; 39(3):539-547. PubMed ID: 31776873 [TBL] [Abstract][Full Text] [Related]
11. Clinical features, therapeutic interventions and long-term aspects of hemolytic-uremic syndrome in Norwegian children: a nationwide retrospective study from 1999-2008. Jenssen GR; Vold L; Hovland E; Bangstad HJ; Nygård K; Bjerre A BMC Infect Dis; 2016 Jun; 16():285. PubMed ID: 27297224 [TBL] [Abstract][Full Text] [Related]
12. Hemolytic uremic syndrome caused by Shiga toxin-producing Escherichia coli in children: incidence, risk factors, and clinical outcome. Ylinen E; Salmenlinna S; Halkilahti J; Jahnukainen T; Korhonen L; Virkkala T; Rimhanen-Finne R; Nuutinen M; Kataja J; Arikoski P; Linkosalo L; Bai X; Matussek A; Jalanko H; Saxén H Pediatr Nephrol; 2020 Sep; 35(9):1749-1759. PubMed ID: 32323005 [TBL] [Abstract][Full Text] [Related]
13. Hyperhydration to Improve Kidney Outcomes in Children with Shiga Toxin-Producing E. coli Infection: a multinational embedded cluster crossover randomized trial (the HIKO STEC trial). Freedman SB; Schnadower D; Estes M; Casper TC; Goldstein SL; Grisaru S; Pavia AT; Wilfond BS; Metheney M; Kimball K; Tarr PI; Trials; 2023 May; 24(1):359. PubMed ID: 37245030 [TBL] [Abstract][Full Text] [Related]
15. Shiga Toxin-Producing Escherichia coli Infection, Antibiotics, and Risk of Developing Hemolytic Uremic Syndrome: A Meta-analysis. Freedman SB; Xie J; Neufeld MS; Hamilton WL; Hartling L; Tarr PI; ; Nettel-Aguirre A; Chuck A; Lee B; Johnson D; Currie G; Talbot J; Jiang J; Dickinson J; Kellner J; MacDonald J; Svenson L; Chui L; Louie M; Lavoie M; Eltorki M; Vanderkooi O; Tellier R; Ali S; Drews S; Graham T; Pang XL Clin Infect Dis; 2016 May; 62(10):1251-1258. PubMed ID: 26917812 [TBL] [Abstract][Full Text] [Related]
16. Shiga toxin-induced haemolytic uraemic syndrome and the role of antibiotics: a global overview. Kakoullis L; Papachristodoulou E; Chra P; Panos G J Infect; 2019 Aug; 79(2):75-94. PubMed ID: 31150744 [TBL] [Abstract][Full Text] [Related]
17. Treatment of Shiga toxin-producing Escherichia coli infections. Davis TK; McKee R; Schnadower D; Tarr PI Infect Dis Clin North Am; 2013 Sep; 27(3):577-97. PubMed ID: 24011831 [TBL] [Abstract][Full Text] [Related]
18. Management of diarrhea-associated hemolytic uremic syndrome in children. Iijima K; Kamioka I; Nozu K Clin Exp Nephrol; 2008 Feb; 12(1):16-9. PubMed ID: 18175052 [TBL] [Abstract][Full Text] [Related]
19. Incidence and etiology of hemolytic-uremic syndrome in children in Norway, 1999-2008--a retrospective study of hospital records to assess the sensitivity of surveillance. Jenssen GR; Hovland E; Bjerre A; Bangstad HJ; Nygard K; Vold L BMC Infect Dis; 2014 May; 14():265. PubMed ID: 24884396 [TBL] [Abstract][Full Text] [Related]